We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ - Free Report) , Wells Fargo (WFC - Free Report) and Wal-Mart (WMT - Free Report) .
Johnson & Johnson shares have bucked the broader healthcare slump this year and are up almost 9% year-to-date. While the company is faced with a number of headwinds like unfavorable currency movements, increased competition from generics, pricing pressures and an uncertain global macroeconomic backdrop, the analyst believes that JNJ's diversified business model, deep product pipeline, lack of cyclicality and financial strength position it for continued momentum going forward.
We saw this in the company's Q3 earnings report when it beat on the top- and bottom-lines and provided favorable outlook. The analyst expects these trends to continue in the coming periods as well. (You can read the full research report on Johnson & Johnson here.)
Wells Fargo has long maintained a reputation for disciplined and reliable operations and an attractive retail banking franchise. Recent quarterly results showing strong growth in loans and deposits reconfirm the bank's inherent strengths, but they have been totally offset lately by the sales practices controversy that has already cost the well regarded CEO his position.
The new management team is making all the right moves and further downside risks in the stock may be low at this stage (the stock is down only 0.1% year to date vs. a roughly 14.6% gain for the peer banks), but it will likely take a while for clouds to fully lifted. (You can read the full research report on Wells Fargo here.)
Wal-Mart’s shares have surpassed those of other supermarkets, gaining more than 14% year-to-date. Though the company is facing a number of headwinds, estimates and share price of Wal-Mart has been rising since the company reported its third-quarter fiscal 2017 results. Wal-Mart posted positive earnings streak for the fifth consecutive quarter, but top-line marginally fell short of expectations after surpassing the same in the preceding two quarters, possibly due to deflationary pressure hurting comparable store sales.
Nevertheless, the analyst likes Wal-Mart’s focus on building its e-commerce capabilities, forays into new markets, expanding product assortments and implementation of innovative ways to drive traffic. (You can read the full research report on Wal-Mart here.)
Other noteworthy reports we are featuring today include Kimberly-Clark (KMB - Free Report) and NIKE (NKE - Free Report) .
Today's Private Buys & Sells from Zacks Research While we share the above news with the public, our sensitive recommendations are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for Zacks' secret trades >>
Mark Vickery
Senior Editor
Note: If you want an email notification each time Zacks Director of Research Sheraz publishes a new article, pleaseclick here>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Top Research Reports for December 6, 2016
Tuesday, December 6 2016
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ - Free Report) , Wells Fargo (WFC - Free Report) and Wal-Mart (WMT - Free Report) .
Johnson & Johnson shares have bucked the broader healthcare slump this year and are up almost 9% year-to-date. While the company is faced with a number of headwinds like unfavorable currency movements, increased competition from generics, pricing pressures and an uncertain global macroeconomic backdrop, the analyst believes that JNJ's diversified business model, deep product pipeline, lack of cyclicality and financial strength position it for continued momentum going forward.
We saw this in the company's Q3 earnings report when it beat on the top- and bottom-lines and provided favorable outlook. The analyst expects these trends to continue in the coming periods as well. (You can read the full research report on Johnson & Johnson here.)
Wells Fargo has long maintained a reputation for disciplined and reliable operations and an attractive retail banking franchise. Recent quarterly results showing strong growth in loans and deposits reconfirm the bank's inherent strengths, but they have been totally offset lately by the sales practices controversy that has already cost the well regarded CEO his position.
The new management team is making all the right moves and further downside risks in the stock may be low at this stage (the stock is down only 0.1% year to date vs. a roughly 14.6% gain for the peer banks), but it will likely take a while for clouds to fully lifted. (You can read the full research report on Wells Fargo here.)
Wal-Mart’s shares have surpassed those of other supermarkets, gaining more than 14% year-to-date. Though the company is facing a number of headwinds, estimates and share price of Wal-Mart has been rising since the company reported its third-quarter fiscal 2017 results. Wal-Mart posted positive earnings streak for the fifth consecutive quarter, but top-line marginally fell short of expectations after surpassing the same in the preceding two quarters, possibly due to deflationary pressure hurting comparable store sales.
Nevertheless, the analyst likes Wal-Mart’s focus on building its e-commerce capabilities, forays into new markets, expanding product assortments and implementation of innovative ways to drive traffic. (You can read the full research report on Wal-Mart here.)
Other noteworthy reports we are featuring today include Kimberly-Clark (KMB - Free Report) and NIKE (NKE - Free Report) .
Today's Private Buys & Sells from Zacks Research
While we share the above news with the public, our sensitive recommendations are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for Zacks' secret trades >>
Mark Vickery
Senior Editor
Note: If you want an email notification each time Zacks Director of Research Sheraz publishes a new article, please click here>>>